{"name":"enGene, Inc.","slug":"engene-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQYmw5SkoxVEYwZldReFJlS0IyLUwxa2hQbUNUa2FMdGNTeTVpTHZmSXNRM3UxeWVaMmRYUU1KNldFU1lGNzBZczdKay1NYzFfb3JFNmtGVmxUT0lSQVh5TjU5V2ducnJ2VzVnb1BiT0lIOW5zbXBBLVk4ZEllRGNwOS1sYVhBRFF2US03WVdpX09ia19iRUlteUg2V2U1NGhHWU1rUllmNFJYYmJleDlMd09PdzBTV1VvSXRDSWdHZmVUQVNBQVJNcENGVWc4NGd2OU5hbTlKd1NWbk1uZmlrVXYwYWRzWXp3cy1HU1lkVW1VWDg2Y1BrdnhibG1ZMnFPYV93bk9WVmpQcFlqME52OHpPRUxoR1RFVlBhMktMazVJU29ZMmdEcTBoMl9FZGhvTm5makctTHNSRTFwSUpr?oc=5","date":"2026-04-03","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and e","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPdWpfRE9DNFBKQTFKRXZxU19sY0tFVnM0NGFfVjRTdkxSSDY5OW9fRzZEMjhMWEE2Vkp2S1dha3RjZU1xTVBhcENZbjE2aHRMTW5iU0tydFRKSUREWHBHRUwzWWxVTGQxRjAza1BJaktUTFNtaUE4allvLU14WU0ybWZSMm9zOXVEVnNWY1Y4ckFRajlUendLZU1LSUZFbTZ6VTRpN2ZNYkUzRHFLdlZWakZ2bjZiX18xRVIzYjNRNld5QmQ2cEdqYWswdHJCVzk3Y0s5YS1DYVZwbVlGb1NvMmpvUjNQamhhaEx1SGlGeXdyRUN0SlhvbkJjYkF2dTd4bTktWFZOalQtRTJiTVVOampJZmVNOEV2eG1MV1pXWEpYRlduMWpZSnFnVTVHSWE2TjV4YVhCN2JIX1Z1dkFTZVpqblA5endudkRoeHRDdTdzZw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - B","headline":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE4tMTcxNmF0MVpzWURrV01QYkN1TG5iOFVLalZqMHNtNGc4YXU2dmxIM2xjN1FqQ255SDdyMUJOVW5mUjhkTU53eGRQWnpwMUdMOXplZDliUEZ6TWsyN3c5UlhOaUdWLVl5eGUxQTVrelU5RWc0T0hpaExiem8zZw?oc=5","date":"2026-02-16","type":"pipeline","source":"Yahoo Finance","summary":"Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN) - Yahoo Finance","headline":"Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQb2dBZUxDTmk1aVlyVzR4elpvZHVQSHdpYkN5X0pZeFlnVUJiR3IzS1d5Q2cyVkt3dk9ZMGw5MnNQVV9IR0dYMEdyQlRzaWRKU3EzcVRNWUh1NUF6UDQ0YkxxN1BjVGFZWVFULUVhN2dzOUptdnpEdFVCSXJxSmtxMEhKWExkbUFzdHdSblN1UXJLRVdkQXI0enpnWWN4Y1h4N2JpTHhfU3VxWmJWNmgtNFhROUtxV0tVUG9NaA?oc=5","date":"2026-02-04","type":"pipeline","source":"Stock Titan","summary":"Hear enGene’s CEO in a live biotech fireside chat on Feb. 11 - Stock Titan","headline":"Hear enGene’s CEO in a live biotech fireside chat on Feb. 11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPWmg4SVdCN2IxdDdCVjFMMmQwU0Uzdm9fUzFJcmJKR3RQRDMzM0hBTi1lTEREUUdJU1VUeE11YXdfM0tMaDljZzZXTlpmc1BtMDFBMl9ZU1dWZ1ZYNzVDUm9keVJvTldJREVzZmRSYjh2eWl2NG1VdHA0YWJscDdKM3NZX3FIWFdiemh6T2ItSGoyUWJqemktOEhuZ1Y3MlNqTnRDVjRkTG5fUHFRNTNiVm00MkVJT0dhd3ZpSjFicGFJRV9GOUNvYUpoZW5obDd5dUdZQg?oc=5","date":"2026-01-20","type":"pipeline","source":"Business Wire","summary":"enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - Business Wire","headline":"enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQeUJWWDhFZGczbDJSTFRmbHAzbVlzdFhDanZONllIQUtSWVB4cGxreXA5WGMyTVJpMzNlS09NZUF5V25pSEZ3ckJMOGZxSGl1VG41TXdncVY1U2tPOVppT2FEcjBWd0t4Z2tJeEVMSFlqVVcyNUMxdUZZVUVSTGdzcHd2WXBQVWtLTXFtNjBOMW1LWGQyU05GclF0MGpxYVVP?oc=5","date":"2025-11-24","type":"pipeline","source":"GuruFocus","summary":"Deep Track Capital, LP Increases Stake in enGene Holdings Inc - GuruFocus","headline":"Deep Track Capital, LP Increases Stake in enGene Holdings Inc","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-14","type":"trial","source":"simplywall.st","summary":"enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results - simplywall.st","headline":"enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPN2Q4bUd5RWFzeTV1ZXdXRHo2aVBqd3RoRFRBeF91MUR2aWNNdWRTbkwwZ3d1cFdka0JzWTNGS01NQ3RXZVAtaG9WRnV4QnFDQWswRTdrZENyQVdXSTJxWS1EZ0tDWVVyLXhaRklQeHhUQmpsbTZaNUlCNzgteWxuSXNVZmJlMW1MRkRsODlFNFdBNDluUDZJdDZtdUZjblNzcDk2RHJxR29xZw?oc=5","date":"2025-11-04","type":"pipeline","source":"BioSpace","summary":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace","headline":"BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-06","type":"pipeline","source":"simplywall.st","summary":"private equity firms who own 38% along with institutions invested in enGene Holdings Inc. (NASDAQ:ENGN) saw increase in their holdings value last week - simplywall.st","headline":"private equity firms who own 38% along with institutions invested in enGene Holdings Inc. (NASDAQ:ENGN) saw increase in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPLUFOTlFUR1h1Um5aSEZESmNRNVZDS1htTHVrcGlQU0kwT0tLaU9TZ3FIdUpaSEx3SlBNeW01QTloREpzVlVWRFZneDZKNi10T0k0TzVSVjQxTEQwSU56QXJPdTk5Y2tVYzZzM3A3bk5MU1h4dUFvV0FpbGg4bnB0VXFDSHViYkxrT0cwWGZ6RDE2akNtNWhTaDRkbFNJLVhMUUtsTS02Sk0?oc=5","date":"2025-06-18","type":"pipeline","source":"seekingalpha.com","summary":"enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) (NASDAQ:ENGN) - seekingalpha.com","headline":"enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) (NASDAQ:ENGN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPMUxIUV9FNTh0UlVURHBmZXFpYXFMUXkwLXZjMzR3N3c1dFoxc01GcXg4MFdBWndQc2VzVE5vaTNqYUc3eXMxNWhJOTZjeFRSb2dpZzU5eXZMV3kyUnp1YzFTNkZJT1FSbVNHVXJzeWxfcjZFWlFQOU1RMEJlOGpHemszMUpuQXNDd2pPVW1MYnc5bzJINk5haVNUbDVaMUJ2STNfRzBXd1FubVhIU0dZbnBmd2JFaThjYnFjdEYwbVQzLWxLdzNn?oc=5","date":"2023-11-01","type":"pipeline","source":"PR Newswire","summary":"enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company - PR Newswire","headline":"enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}